#1
#1 out of 1
health9h ago
Fitterfly (a division of PB Health) Secures Patent for PGR Technology to Drive Better Diabetes Outcomes
- Fitterfly, a division of PB Health, secured the government patent for its Personalised Glycemic Response (PGR) technology.
- PGR uses an AI-led engine to predict blood sugar impact up to three hours ahead to guide care.
- The patent is supported by data from over 10,000,000 CGM readings and 1,21,000 meals.
- Fitterfly’s PGR aims to reduce daily food-related decisions for people with diabetes.
- The patent strengthens Fitterfly’s ability to deliver scalable, personalized diabetes care.
- In 2025, a high proportion of members with high HbA1c saw notable improvements within 6–12 months.
- Fitterfly recently merged with PB Health, expanding its preventive and digital health initiative.
- PB Health aims to shift healthcare from treatment to long-term health stability.
- The release notes ongoing insurer collaborations to integrate similar programs.
- The PGR approach supports continuous, outcome-led diabetes management.
Vote 0